OALib Journal期刊
ISSN: 2333-9721
费用:99美元
|
|
|
酪氨酸激酶抑制剂的研究新进展
Keywords: 酪氨酸激酶,抑制剂,ATP,药效团模型
Abstract:
蛋白质酪氨酸在一系列细胞活动的信号转导途径中起着重要的作用。在包括癌症和其他许多疾病的治疗研究中,酷氨酸激酶都是研究的目标和对象。本文综述了近年来酷氨酸激酶抑制剂的研究进展,包括抑制剂的结构和与激酶作用的药效团模型。
References
[1] | [ 2 ] Fry D W. Exp. Opin. Invest. Drugs, 1994, 3: 577—595
|
[2] | [ 3 ] Traxler P, Lydon N. Drugs Future, 1995, 20: 1261—1274
|
[3] | [ 4 ] 韩锐. 肿瘤化学预防及药物治疗. 北京: 北京医科大学出版社, 1991. 182
|
[4] | [ 10 ] Rewcastle G, Palmer B, Bredges A , et al. J. Med.Chem. , 1996, 39: 918—928
|
[5] | [ 11 ] Rewcastle G, Palmer B, Thompson A , et al. J. Med.Chem. , 1996, 39: 1823—1835
|
[6] | [ 12 ] Palmer B, Trumpp-Kallmeyer S, Fry D, et al. J. Med.Chem. , 1997, 40: 1519—1529
|
[7] | [ 18 ] Smaill J , Rewcastle G, Loo J , et al. J. Med. Chem. ,2000, 43: 1380—1397
|
[8] | [ 19 ] Smaill J , Showalter H, Zhou H, et al. J. Med. Chem. ,2001, 44: 429—440
|
[9] | [ 20 ] Bo schelli D, W u Z, Kltchko S, et al. J. Med. Chem. ,1998, 41: 4365—4377
|
[10] | [ 21 ] Traxler P, Green J , Mett H, et al. J. Med. Chem. ,1999, 42: 1018—1026
|
[11] | [ 22 ] Traxler P. Exp. Opin. Ther. Patents. , 1997, 7: 571—588
|
[12] | [ 24 ] Traxler P, Bold G, Frei J , et al. J. Med. Chem. , 1997,40: 3601—3616
|
[13] | [ 25 ] Sun L , Tran N , Tang F, et al. J. Med. Chem. , 1998,41: 2588—2603
|
[14] | [ 26 ] Hennequin L , Thomas A , Johnstone C, et al. J. Med.Chem. , 1999, 42: 5369—5389
|
[15] | [ 27 ] 庞素华(Pang S H) , 郭宗儒(Guo Z R) , 梁晓天(Liang X T). 药学学报(Acta Pharma. Sinica) , 1997, 32 (7) : 515—523
|
[16] | [ 28 ] Furet P, Caravatti G, Lydon N , et al. J. Comput. Aided Mol. Des. , 1995, 9: 465—471
|
[17] | [ 29 ] Traxler P, Furet P. Phamacol. Ther. , 1999, 82: 195—206
|
[18] | [ 30 ] Palmer B D, Trumpp-Kallmeyer S, Fry D W , et al. J.Med. Chem. , 1997, 40: 1519—1529
|
[19] | [ 31 ] Trumpp-Kallmeyer S, Rubin J R, Humblet C, et al. J.Med. Chem. , 1998, 41: 1752—1763
|
[20] | [ 32 ] 郭宗儒(Guo Z R) , 后藤了(Goto S) , 杨光中(Yang G Z)等. 药学学报(Acta Pharma. Sinica) , 1992, 27 (2) : 90—95
|
[21] | [ 33 ] 廖宁(Liao N ) , 侯廷军(Hou T J ) , 陈丽蓉(Chen L R) 等.计算机与应用化学(Computer and Applied Chemistry) ,2000, 17 (1) : 37—38
|
[22] | [ 1 ] Burker T R. Drugs Future, 1992, 17: 119—131
|
[23] | [ 5 ] Graziani Y, Chayoth R, Karny N , et al. Biochem. Biophys. Acta, 1981, 714: 415—433
|
[24] | [ 6 ] 庞素华(Pang S H) , 郭宗儒(Guo Z R ). 药学学报(Acta Pharma. Sinica) , 1996, 31 (1) : 75—80
|
[25] | [ 7 ] Fry D W , Kraker A J , McMichael A , et al. Science,1994, 265: 1093—1095
|
[26] | [ 8 ] Showalter H, Sercel A , Leja B, et al. J. Med. Chem. ,1997, 40: 413—426
|
[27] | [ 9 ] Bredges A , Zhou H, Cody D, et al. J. Med. Chem. ,1996, 39: 267—276
|
[28] | [ 13 ] Rewcastle G, Bridges A , Fry D, et al. J. M ed. Chem. ,1997, 40: 1820—1826
|
[29] | [ 14 ] Thompson A , Murray D, Elliott W , et al. J. Med.Chem. , 1997, 40: 3915—3925
|
[30] | [ 15 ] Rewcastle G, Murray D, Elliott W , et al. J. Med.Chem. , 1998, 41: 742—751
|
[31] | [ 16 ] Smaill J , Palmer B, Rewcastle G, et al. J. Med. Chem. ,1999, 42: 1803—1815
|
[32] | [ 17 ] Showalter H, Gridges A , Zhou H, et al. J. Med. Chem. ,1999, 42: 5464—5474
|
[33] | [ 23 ] Traxler P, Furet P, Mett H, et al. J. Med. Chem. ,1996, 38: 2285—2292
|
Full-Text
|
|
Contact Us
service@oalib.com QQ:3279437679 
WhatsApp +8615387084133
|
|